BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33226963)

  • 1. Identification of the novel Np17 oncogene in human leukemia.
    Wu B; Gan Y; Xu Y; Wu Z; Xu G; Wang P; Wang C; Meng Z; Li M; Zhang J; Zhuang H; Zhang X; Yang L; Li J; Gan X; Yu X; Huang W; Gu Y; Xu R
    Aging (Albany NY); 2020 Nov; 12(23):23647-23667. PubMed ID: 33226963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells.
    Chen T; Meng Z; Gan Y; Wang X; Xu F; Gu Y; Xu X; Tang J; Zhou H; Zhang X; Gan X; Van Ness C; Xu G; Huang L; Zhang X; Fang Y; Wu J; Zheng S; Jin J; Huang W; Xu R
    Leukemia; 2013 Jul; 27(7):1469-78. PubMed ID: 23307033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Np9, a cellular protein of retroviral ancestry restricted to human, chimpanzee and gorilla, binds and regulates ubiquitin ligase MDM2.
    Heyne K; Kölsch K; Bruand M; Kremmer E; Grässer FA; Mayer J; Roemer K
    Cell Cycle; 2015; 14(16):2619-33. PubMed ID: 26103464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
    Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
    Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 inhibition-mediated autophagy contributes to the pro-apoptotic effect of berberine in p53-null leukemic cells.
    Liu J; Zhu Z; Liu Y; Wei L; Li B; Mao F; Zhang J; Wang Y; Liu Y
    Life Sci; 2020 Feb; 242():117228. PubMed ID: 31881227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
    Yang G; Gong Y; Wang Q; Wang L; Zhang X
    Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.
    Maganti HB; Jrade H; Cafariello C; Manias Rothberg JL; Porter CJ; Yockell-Lelièvre J; Battaion HL; Khan ST; Howard JP; Li Y; Grzybowski AT; Sabri E; Ruthenburg AJ; Dilworth FJ; Perkins TJ; Sabloff M; Ito CY; Stanford WL
    Cancer Discov; 2018 Nov; 8(11):1376-1389. PubMed ID: 30115703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the MDM2 oncogene in leukemia and lymphoma.
    Watanabe T; Ichikawa A; Saito H; Hotta T
    Leuk Lymphoma; 1996 May; 21(5-6):391-7, color plates XVI following 5. PubMed ID: 9172803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.
    Guo Y; Li Y; Wang FF; Xiang B; Huang XO; Ma HB; Gong YP
    Int J Biochem Cell Biol; 2019 Jan; 106():8-20. PubMed ID: 30389549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
    Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
    Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation.
    Zhang JM; Wang CC; Zhang GC; Jiang Q; Yang SM; Fu HX; Wang QM; Zhu XL; Zhu HH; Jiang H; Wang Y; Lv M; Lu J; Chen H; Han W; Chang YJ; Kong Y; Xu LP; Liu KY; Huang XJ; Zhang XH
    Cancer Lett; 2019 Feb; 442():193-201. PubMed ID: 30429106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of p53 and MDM2 proteins in hematological malignancies.
    Koníková E; Kusenda J
    Neoplasma; 2003; 50(1):31-40. PubMed ID: 12687276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meis2 as a critical player in MN1-induced leukemia.
    Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
    Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of WT1 gene expression in regulation of P53 and MDM2 proteins function in acute lymphoblastic leukemia].
    Bartkowiak J; Wójcik I; Stankiewicz W
    Pol Merkur Lekarski; 2001 Nov; 11(65):402-5. PubMed ID: 11852808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells.
    Urashima M; Teoh G; Chauhan D; Ogata A; Shirahama S; Kaihara C; Matsuzaki M; Matsushima H; Akiyama M; Yuza Y; Maekawa K; Anderson KC
    Blood; 1998 Aug; 92(3):959-67. PubMed ID: 9680365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
    Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
    J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1.
    Xu X; Han K; Tang X; Zeng Y; Lin X; Zhao Y; Zhang Z; Cao B; Wu D; Mao X
    J Biol Chem; 2016 Apr; 291(18):9617-28. PubMed ID: 26971355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.